{"id":"NCT02251938","sponsor":"Santen Inc.","briefTitle":"A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program","officialTitle":"A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-29","primaryCompletion":"2017-11-01","completion":"2017-11-27","firstPosted":"2014-09-29","resultsPosted":"2020-02-12","lastUpdate":"2020-02-12"},"enrollment":60,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Infectious Uveitis of the Posterior Segment of the Eye"],"interventions":[{"type":"DRUG","name":"DE-109 440 μg","otherNames":["Sirolimus"]}],"arms":[{"label":"DE-109 Sirolimus","type":"EXPERIMENTAL"}],"summary":"The objective of this extension study is to evaluate the long-term safety of treatment with DE-109 (440 μg) in subjects with non-infectious uveitis of the posterior segment of the eye who have participated in the SAKURA development program.","primaryOutcome":{"measure":"Change From Baseline in Best Corrected Visual Acuity (BCVA) at Month 12 in the Study Eye","timeFrame":"Day 1 (Baseline) and Month 12 or early termination visit","effectByArm":[{"arm":"DE-109 440 μg","deltaMin":2.1,"sd":11.35}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":25,"countries":["United States","Austria","France","India","Italy","Turkey (Türkiye)"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":60},"commonTop":["Uveitis","Intraocular Pressure Increased","Cystoid Macular Oedema","Intermediate Uvei","Iridocyclitis"]}}